XML 31 R15.htm IDEA: XBRL DOCUMENT v3.24.4
Revenue
12 Months Ended
Oct. 31, 2024
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
Disaggregated Revenue
The following table shows the percentage of revenue by product groups:
Year Ended October 31,
202420232022
EDA66.4 %69.2 %69.2 %
Design IP31.1 %29.0 %28.5 %
Other2.5 %1.8 %2.3 %
Total100.0 %100.0 %100.0 %
Contract Balances
The contract assets indicated below are presented as prepaid and other current assets in the consolidated balance sheets. The contract assets are transferred to receivables when the rights to invoice and receive payment become unconditional. Unbilled receivables are presented as accounts receivable, net, in the consolidated balance sheets.
Contract balances are as follows:
As of October 31,
20242023
 (in thousands)
Contract assets, net$757,075 $375,904 
Unbilled receivables$44,166 $60,016 
Deferred revenue$1,732,568 $1,710,288 
During fiscal 2024, we recognized revenue of $1.5 billion, that was included in the deferred revenue balance as of October 31, 2023, including previously unfulfilled contracts that have expired and are no longer subject to an implied promise to provide future services. During fiscal 2023, we recognized revenue of $1.5 billion, that was included in the deferred revenue balance as of October 31, 2022, including previously unfulfilled contracts that have expired and are no longer subject to an implied promise to provide future services.
Contracted but unsatisfied or partially unsatisfied performance obligations (backlog) were approximately $8.1 billion as of October 31, 2024, which includes $1.2 billion in non-cancellable Flexible Spending Account (FSA) commitments from customers where actual product selection and quantities of specific products or services are to be determined by customers at a later date. We have elected to exclude future sales-based royalty payments from the remaining performance obligations. Approximately 41% of the backlog as of October 31, 2024, excluding non-cancellable FSA, is expected to be recognized as revenue over the next 12 months, with the remainder to be recognized thereafter. The majority of the remaining backlog is expected to be recognized in the following three years. The backlog was approximately $8.1 billion as of October 31, 2023, which included $1.4 billion in non-cancellable FSA commitments from customers.
During fiscal 2024 and 2023, we recognized $104.4 million and $99.3 million, respectively, from performance obligations satisfied from sales-based royalties earned during the periods.
Costs of Obtaining a Contract with Customer
The incremental costs of obtaining a contract with a customer, which consist primarily of direct sales commission earned upon execution of the contract, were capitalized in compliance with authoritative guidance, and amortized over the estimated period of which the benefit is expected to be received. As direct sales commission paid for renewals are commensurate with the amounts paid for initial contracts, the deferred incremental costs will be recognized over the contract term.
Capitalized commission costs, net of accumulated amortization, as of October 31, 2024 and 2023 were $72.8 million and $67.2 million, respectively. The balances are included in other long-term assets in our consolidated balance sheets. Amortization of these assets were $48.5 million, $52.1 million and $49.9 million during fiscal 2024, 2023 and 2022, respectively, and are included in sales and marketing expense in our consolidated statements of income.